SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divis Laboratories rises on successful inspection of Telangana unit

17 May 2018 Evaluate

Divis Laboratories is currently trading at Rs. 1177.95, up by 11.80 points or 1.01% from its previous closing of Rs. 1166.15 on the BSE.

The scrip opened at Rs. 1194.00 and has touched a high and low of Rs. 1213.00 and Rs. 1174.50 respectively. So far 23,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1220.00 on 11-May-2018 and a 52 week low of Rs. 533.10 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 1220.00 and Rs. 1125.00 respectively. The current market cap of the company is Rs. 31,270.00 crore.

The promoters holding in the company stood at 52.05%, while Institutions and Non-Institutions held 34.18% and 13.77% respectively.

Divis Laboratories’ Unit-I at Choutuppal in state of Telangana has been inspected by the United States Food & Drug Administration (USFDA) from May 14 to May 16, 2018. This was a general cGMP inspection by the USFDA. The inspection has been concluded with no 483 observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

6381.80 3.05 (0.05%)
24-Apr-2026 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.70
Dr. Reddys Lab 1327.00
Cipla 1300.90
Zydus Lifesciences 930.65
Lupin 2285.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×